inflammatori
demyelin
diseas
heterogen
group
disord
occur
background
acut
chronic
inflammatori
process
patholog
hallmark
multipl
sclerosi
ms
presenc
focal
demyelin
lesion
partial
axon
preserv
reactiv
astrogliosi
demyelin
plaqu
present
white
well
gray
matter
cerebr
cerebellar
cortex
brainstem
nuclei
activ
diseas
process
reflect
presenc
lesion
ongo
myelin
destruct
axon
neuron
destruct
lesion
major
substrat
perman
neurolog
deficit
ms
patient
ms
patholog
qualit
similar
differ
diseas
stage
relaps
remit
ms
secondari
primari
progress
ms
preval
differ
lesion
type
differ
quantit
acut
ms
balo
type
concentr
sclerosi
appear
variant
classic
ms
contrast
neuromyel
optica
nmo
spectrum
disord
nmosd
inflammatori
diseas
primari
injuri
astrocyt
mediat
antibodi
final
discuss
histopatholog
inflammatori
demyelin
diseas
acut
dissemin
encephalomyel
myelin
oligodendrocyt
glycoprotein
antibodyassoci
demyelin
knowledg
heterogen
immunopatholog
demyelin
diseas
import
understand
clinic
present
diseas
cours
find
optim
treatment
individu
patient
histor
first
descript
multipl
sclerosi
ms
neuropatholog
entiti
date
charcot
subsequ
less
preval
disord
neuromyel
optica
nmo
devic
marburg
type
ms
marburg
concentr
sclerosi
balo
demonstr
consid
subtyp
ms
avail
immunohistochem
marker
becam
appar
consider
patholog
distinct
disord
morpholog
pattern
associ
differ
mechan
demyelin
lucchinetti
et
al
lucchinetti
et
al
observ
support
discoveri
autoantibodi
associ
specif
spectrum
demyelin
diseas
antibodi
associ
nmo
limit
form
diseas
isol
optic
neuriti
myeliti
subsum
term
nmo
spectrum
disord
nmosd
meanwhil
use
biomark
nmosd
well
establish
major
prognost
therapeut
implic
antimyelin
oligodendrocyt
glycoprotein
mog
antibodi
found
patient
acut
dissemim
encephalomyel
adem
nmosd
rare
mslike
clinic
present
lennon
et
al
kim
et
al
wingerchuk
et
al
sepulveda
et
al
may
defin
uniqu
specif
variant
inflammatori
demyelin
diseas
quit
probabl
even
within
classic
spectrum
ms
variabl
may
repres
differ
diseas
process
perhap
differ
trigger
factor
classifi
futur
distinct
entiti
clinic
diagnosi
ms
base
demonstr
demyelin
lesion
dissemin
time
space
addit
neurolog
symptom
find
magnet
reson
imag
mri
lesion
consist
ms
barkhof
et
al
tintor
et
al
demonstr
oligoclon
band
cerebrospin
fluid
csf
link
tibbl
andor
detect
abnorm
visual
evok
potenti
delay
wellpreserv
wave
form
recommend
provid
correct
diagnosi
mcdonald
et
al
patient
ms
may
present
monosymptomat
diseas
suggest
ms
clinic
isol
syndrom
classic
relaps
remit
cours
primari
secondari
progress
diseas
diseas
progress
defin
continu
deterior
neurolog
symptom
despit
new
mri
lesion
rare
incid
contrastenhanc
lesion
major
patient
ms
start
relaps
remit
ms
later
convert
secondari
progress
diseas
primari
progress
ms
diseas
start
continu
progress
onset
pathogenet
mechan
underli
progress
suppos
result
least
part
ongo
inflammatori
reaction
behind
close
bloodbrain
barrier
bbb
histopatholog
hallmark
ms
format
inflammatori
demyelin
lesion
variabl
axon
damag
astrocyt
gliosi
pathogenesi
ms
plaqu
current
suppos
autoreact
myelinspecif
lymphocyt
activ
outsid
central
nervou
system
cn
cross
bbb
form
new
inflammatori
demyelin
lesion
ciccarelli
et
al
cross
bbb
depend
interact
integrin
surfac
lymphocyt
cell
adhes
molecul
endotheli
cell
takeshita
ransohoff
one
import
interact
bind
late
integrin
lymphocyt
vascular
cell
adhes
brain
vascular
endothelium
takeshita
ransohoff
therapeut
block
monoclon
antibodi
natalizumab
relaps
remit
ms
polman
et
al
high
efficaci
natalizumab
treatment
due
blockad
migrat
mani
differ
inflammatori
cell
type
howev
suggest
differ
inflammatori
cell
type
use
differ
entri
pathway
use
distinctli
differ
adhes
molecul
interact
chemokin
icam
alcam
cell
engelhardt
ransohoff
cayrol
et
al
ifergan
et
al
monocyt
man
et
al
paradi
et
al
observ
confirm
valid
differ
human
diseas
includ
ms
specif
blockad
migrat
leukocyt
relev
drive
diseas
tissu
damag
may
lead
effect
therapi
fewer
sideeffect
compar
current
avail
morpholog
disturb
bbb
permeabl
visual
ultrastructur
investig
immunohistochemistri
ultrastructur
endotheli
cell
show
increas
pinocyt
vesicl
activ
ms
lesion
brown
immunohistochemistri
perivascular
leakag
serum
protein
specif
express
molecular
marker
leaki
endotheli
cell
seen
kirk
et
al
hochmeist
et
al
mri
studi
bbb
permeabl
visual
contrast
enhanc
dynam
chang
nodular
enhanc
earli
lesion
format
ringenhanc
lesion
later
stage
suggest
bbb
leakag
init
start
inflam
central
vein
later
mainli
occur
activ
margin
gaitan
et
al
import
note
contrast
enhanc
mri
depict
bbb
leakag
direct
marker
inflamm
particular
patient
progress
ms
widespread
profound
inflamm
seen
brain
take
place
part
behind
close
repair
bbb
hochmeist
et
al
neuropatholog
tissu
examin
recogn
perivascular
cell
cuff
mening
inflammatori
infiltr
compos
cell
cell
b
cell
plasma
cell
present
variabl
lower
number
frischer
et
al
lymphocyt
inflamm
associ
profound
macrophag
infiltr
microglia
activ
particular
lesion
activ
demyelin
tissu
injuri
neutrophil
eosinophil
usual
observ
characterist
lesion
nmo
parenchyma
ms
plaqu
r
h
oftberg
h
lassmann
inflammatori
infiltr
domin
cell
fries
fugger
show
clonal
expans
persist
time
babb
et
al
case
larg
number
cytotox
cell
identifi
close
contact
oligodendrocyt
axon
show
polar
granzym
b
toward
site
contact
neumann
et
al
reason
hypothes
cytotox
cell
may
part
select
mediat
inflammatori
demyelin
ms
view
support
experiment
model
brain
inflamm
induc
oligodendrocytereact
cell
unequivoc
show
primari
demyelin
saxena
et
al
howev
turn
difficult
induc
demyelin
passiv
transfer
cell
anim
model
husebi
et
al
na
et
al
saxena
et
al
partli
explain
antigenspecif
clonal
delet
cytotox
cell
oligodendrocyt
intact
cn
na
et
al
effect
could
abolish
immunolog
prime
cn
infecti
process
na
et
al
altern
theori
suggest
least
subpopul
cell
may
play
neuroprotect
rather
destruct
role
support
also
detect
hlae
endotheli
cell
astrocyt
activ
ms
lesion
induc
immunoregulatori
phenotyp
cell
durrenberg
et
al
interestingli
lower
number
circul
regulatori
cell
circul
relaps
ms
patient
compar
remiss
detect
held
respons
ongo
autoimmun
attack
ms
lesion
boppana
et
al
number
cell
within
ms
lesion
low
fritzsch
et
al
cell
present
variabl
amount
perivascular
mening
inflammatori
infiltr
number
overal
small
clonal
expans
rare
comparison
cell
babb
et
al
believ
helper
cell
initi
format
ms
lesion
recruit
macrophag
subsequ
present
antigen
antigen
drive
autoimmun
process
howev
unknown
suppos
antigen
epitop
repertoir
may
increas
chang
time
call
epitop
spread
davi
et
al
theori
helper
cell
respons
format
new
demyelin
lesion
support
anim
model
experiment
autoimmun
encephalomyel
eae
mainli
induc
tcelldriven
inflamm
billiau
matthi
howev
ms
therapi
select
target
tcell
respons
shown
ineffect
van
oosten
et
al
segal
et
al
b
cell
spars
parenchyma
ms
lesion
comparison
cell
frischer
et
al
b
cell
plasma
cell
mainli
found
perivascular
mening
inflammatori
infiltr
patient
pronounc
inflammatori
patholog
larg
bcell
aggreg
may
occur
show
featur
tertiari
lymphoid
follicl
germin
centerlik
structur
organ
serafini
et
al
aloisi
pujolborrel
magliozzi
et
al
shown
mening
inflamm
correl
extent
activ
demyelin
neurodegener
underli
cortex
see
later
demyelin
lesion
gray
matter
magliozzi
et
al
howel
et
al
fischer
et
al
b
cell
matur
plasma
cell
produc
immunoglobulin
mainli
isotyp
less
frequent
iga
igm
isotyp
lipidspecif
igm
csf
document
patient
ms
may
reflect
neg
prognost
marker
thangarajh
et
al
igproduc
b
cell
undergo
antigenspecif
clonal
expans
support
promin
somat
hypermut
ig
chain
within
csf
brain
lesion
ms
patient
obermei
et
al
beltran
et
al
although
exact
role
b
lymphocyt
format
ms
lesion
still
unclear
patient
show
good
respons
therapi
target
tand
bcell
infiltr
cn
alemtuzumab
thompson
et
al
select
elimin
circul
b
cell
rituximab
ocrelizumab
hauser
et
al
montalban
et
al
number
macrophag
within
ms
lesion
depend
stage
activ
activ
demyelin
plaqu
contain
high
number
lipidladen
macrophag
throughout
lesion
chronic
activ
plaqu
delin
rim
macrophag
activ
microglia
lesion
center
devoid
macrophag
chronic
inact
plaqu
contain
hardli
macrophag
kuhlmann
et
al
role
microglia
macrophag
pathogenesi
ms
plaqu
extens
studi
last
decad
origin
mainli
seen
proinflammatori
cell
exacerb
tissu
damag
antigen
present
via
major
histocompat
complex
mhc
molecul
product
oxygen
nitric
oxid
radic
secret
proinflammatori
cytokin
phagocytosi
macrophag
use
paramet
time
stage
ms
lesion
base
presenc
partli
digest
myelin
compon
within
cytoplasm
bruck
et
al
vitro
mog
myelinassoci
glycoprotein
mag
degrad
day
fig
degrad
proteolipid
protein
plp
myelin
basic
protein
much
slower
follow
myelin
phagocytosi
fig
van
der
goe
et
al
immunohistochem
stain
myelin
protein
give
indic
time
interv
actual
myelin
destruct
analysi
tissu
bruck
et
al
later
stage
residu
glycoprotein
macrophag
lysosom
stain
period
acidschiff
fig
c
later
becam
clear
macrophag
may
also
involv
remyelin
neuroprotect
matur
antiinflammatori
phenotyp
occur
ingest
myelin
boven
et
al
far
howev
clear
lesion
stagedepend
macrophag
polar
becom
appar
macrophag
microglia
show
phenotyp
intermedi
cell
vogel
et
al
myelin
sheath
form
maintain
oligodendrocyt
dhaunchak
nave
myelin
assembl
longterm
preserv
requir
number
protein
either
express
myelin
axon
membran
mog
local
outermost
surfac
myelin
sheath
protein
belong
immunoglobulin
superfamili
might
serv
cell
adhes
molecul
regul
microtubul
stabil
mediat
interact
myelin
immun
system
john
bernard
structur
myelin
protein
proteolipid
protein
myelin
basic
protein
necessari
exact
membranetomembran
space
wherea
nucleotid
cnp
mag
express
peripheri
oligodendrocyt
latter
play
role
link
innermost
periaxon
loop
oligodendrocyt
axon
lappesiefk
et
al
node
ranvier
axogli
protein
like
form
glioaxon
junction
keep
sodium
channel
nodal
region
critic
effici
saltatori
conduct
action
potenti
sherman
et
al
demyelin
common
final
phase
patholog
ms
compris
strip
myelin
lamella
remov
myelin
fragment
phagocyt
evid
demyelin
driven
differ
mechan
involv
adapt
innat
immun
system
lucchinetti
et
al
diffus
oxygen
nitric
oxid
nitrogen
speci
mainli
produc
macrophag
activ
microglia
key
mechan
myelin
oligodendrocyt
damag
earli
demyelin
hill
et
al
haider
et
al
subgroup
patient
pattern
rel
indiscrimin
damag
probabl
major
mechan
injuri
patient
short
aggress
diseas
cours
addit
deposit
immunoglobulin
complement
shown
within
lesion
suggest
antibodymedi
process
pattern
first
evid
direct
antibodyantigen
interact
gain
eae
model
induc
encephalitogen
cell
modifi
monoclon
antibodi
mog
schluesen
et
al
linington
et
al
later
autoantibodi
astrocyt
waterchannel
discov
sensit
specif
diagnost
marker
nmosd
indirect
evid
antibodymedi
damag
found
patient
igm
antibodi
deposit
myelin
demyelin
axon
coloc
complement
next
antibodyantigen
immuncomplex
macrophag
sadaba
et
al
anoth
distinct
group
patient
oxid
stress
may
caus
oligodendrogliopathi
start
distal
process
oligodendrocyt
preferenti
loss
mag
later
result
apoptosi
oligodendrocyt
pattern
r
h
oftberg
h
lassmann
sinc
preferenti
mag
loss
promin
featur
earli
whitematt
stroke
type
viral
enceph
marker
hypoxia
strongli
express
lesion
hypothes
dyingback
oligodendrogliopathi
may
result
hypoxialik
tissu
injuri
may
induc
disturb
microcircul
impair
mitochondri
energi
metabol
result
reactiv
oxygen
speci
produc
macrophag
aboulenein
et
al
mahad
et
al
final
case
identifi
apoptot
oligodendrocyt
normalappear
white
matter
nawm
suggest
primari
oligodendrogliopathi
patient
pattern
howev
case
need
elucid
underli
pathogenet
mechan
ms
lesion
aris
site
cn
fig
howev
predilect
area
high
venou
densiti
relat
fact
vein
prime
site
egress
inflammatori
cell
blood
brain
waksman
progress
ms
lesion
addit
accumul
watersh
area
low
arteri
blood
suppli
periventricular
white
matter
haider
et
al
attribut
amplif
oxid
injuri
histotox
hypoxia
area
reduc
arteri
perfus
oxygen
suppli
demyelin
lesion
typic
well
demarc
center
inflam
vein
fingerlik
protrus
may
occur
along
inflam
vein
call
dawson
finger
classic
activ
lesion
activ
demyelin
lesion
mainli
found
biopsi
specimen
autopsi
tissu
patient
die
earli
diseas
onset
fig
frischer
et
al
activ
lesion
character
numer
macrophag
earli
myelin
degrad
product
within
cytoplasm
express
earli
macrophag
marker
fig
b
moreov
consider
number
cell
variabl
number
perivascular
mening
b
cell
plasma
cell
visibl
fig
cf
within
lesion
remain
oligodendrocyt
show
sign
activ
larg
round
nuclei
broaden
cytoplasm
may
reflect
earli
remyelin
goldschmidt
et
al
hoftberg
et
al
entir
lesion
fill
myelincontain
macrophag
lesion
call
acut
plaqu
chronic
activ
lesion
present
myelincontain
macrophag
dens
pack
edg
lesion
inact
core
acut
axon
damag
amyloid
precursor
proteinposit
spheroid
abund
within
activ
plaqu
kuhlmann
et
al
astrocyt
strongli
activ
enlarg
cytoplasm
often
bizarr
multipl
nuclei
socal
creutzfeldt
cell
form
protoplasm
gliosi
astrocyt
chang
like
nonspecif
seem
consequ
sever
inflamm
microglia
activ
sharma
et
al
howev
activ
astrocyt
produc
larg
number
proinflammatori
cytokin
chemokin
therefor
cell
may
also
involv
propag
inflamm
tissu
damag
brosnan
rain
smolder
slowli
expand
lesion
lesion
mainli
seen
patient
progress
ms
frischer
et
al
show
rim
activ
microglia
edg
lesion
center
inact
fig
ad
contain
macrophag
edg
digest
myelin
compon
fig
accompani
scatter
cell
fig
e
f
suggest
ongo
expans
surround
nawm
slow
expans
lesion
within
timefram
year
demonstr
recent
prospect
mri
studi
dalbianco
et
al
acut
axon
injuri
promin
edg
lesion
moreov
accumul
iron
demonstr
microglia
lesion
edg
result
microgli
dystrophi
remyelin
absent
hametn
et
al
drive
forc
lead
continu
expans
lesion
still
unclear
sinc
autolog
stem
cell
transplant
fail
termin
diseas
progress
hypothes
cnsresid
immun
respons
might
involv
metz
et
al
chronic
inact
lesion
longstand
ms
common
lesion
type
chronic
inact
demyelin
lesion
lesion
usual
hypocellular
center
may
show
thin
myelin
sheath
edg
repres
remyelin
fig
macrophag
cell
found
present
mainli
perivascular
space
fig
h
although
myelin
primari
target
ms
also
pronounc
axon
damag
lead
averag
axon
loss
compar
control
white
matter
newli
form
lesion
van
waesbergh
et
al
kornek
et
al
lova
et
al
chronic
establish
lesion
mew
et
al
bjartmar
et
al
astrocyt
form
dens
fibrillari
gliosi
addit
predilect
site
white
matter
cortex
especi
vulner
demyelin
cortic
demyelin
like
found
chronic
diseas
stage
kutzelnigg
et
al
associ
cognit
deficit
patient
epilepsi
lesion
locat
subpial
intracort
overlap
white
matter
socal
compound
plaqu
kidd
et
al
subpial
lesion
diseasespecif
ms
moll
et
al
fischer
et
al
subpial
lesion
often
extend
sever
gyri
sulci
cover
cortex
patient
fig
b
kutzelnigg
et
al
intracort
lesion
mostli
small
inconspicu
fig
compound
plaqu
affect
cortex
underli
white
matter
mostli
inflammatori
microgli
astrogli
activ
compar
cortic
lesion
type
fig
peterson
et
al
subpial
cortic
lesion
associ
inflammatori
infiltr
adjac
mening
pronounc
invagin
brain
surfac
like
due
compar
low
csf
flow
area
haider
et
al
hypothes
solubl
mediat
diffus
cortex
induc
tissu
damag
either
directli
indirectli
microglia
activ
oxid
stress
howel
et
al
fischer
et
al
patient
ms
cortic
plaqu
howev
accumul
mening
inflamm
chronic
diseas
age
patient
accumul
iron
brain
lassmann
distant
lesion
within
white
deep
gray
matter
topograph
relat
cortex
kolasinski
et
al
may
play
role
vulner
remyelin
demyelin
lesion
occur
spontan
often
structur
function
incomplet
remyelin
mediat
oligodendrocyt
precursor
cell
opc
present
normal
white
matter
remyelin
opc
activ
subsequ
migrat
lesion
undergo
differenti
myelingener
cell
remyelin
fiber
character
thinner
myelin
sheath
may
encount
border
zone
lesion
also
fulli
remyelin
lesion
call
shadow
plaqu
fig
ac
shadow
plaqu
may
undergo
new
demyelin
either
within
overlap
previous
remyelin
area
prinea
et
al
bramow
et
al
extent
remyelin
vari
consider
patient
seem
preval
earli
stage
diseas
lesion
inflamm
macrophag
activ
foot
blakemor
repair
capac
also
depend
lesion
site
periventricular
lesion
show
less
extens
remyelin
patrikio
et
al
lack
remyelin
consider
number
patient
attribut
failur
opc
r
h
oftberg
h
lassmann
differenti
may
influenc
age
hormon
chang
et
al
chari
et
al
kotter
et
al
loss
axon
lesion
charl
et
al
loss
macrophag
chronic
lesion
earli
late
stage
ms
axon
neuron
synaps
damag
commonli
term
neurodegener
peterson
et
al
dutta
trapp
axon
loss
suggest
substrat
perman
motor
disabl
ms
tallantyr
et
al
acut
axon
damag
pronounc
activ
demyelin
lesion
visual
immunohistochemistri
amyloid
precursor
protein
reflect
disturb
fast
axon
transport
dystroph
axon
ferguson
et
al
trapp
et
al
kuhlmann
et
al
loss
myelin
contribut
axon
damgag
loss
trophic
factor
moreov
oxid
injuri
directli
damag
axon
addit
antibodi
identifi
target
glioaxon
protein
juxtaparanod
area
mathey
et
al
later
turn
play
import
role
proport
patient
chronic
inflammatori
demyelin
polyneuropathi
ng
et
al
chronic
ms
lesion
axon
markedli
reduc
consid
contribut
failur
remyelin
kornek
et
al
neuron
damag
may
consequ
retrograd
neurodegener
axon
transect
morpholog
associ
chromatolysi
neuron
cell
bodi
haider
et
al
case
loss
neuron
topograph
relat
whitematt
lesion
loss
neuron
pronounc
deep
layer
cortex
deep
graymatt
nuclei
thalamu
globu
pallidu
hand
neuron
damag
may
directli
mediat
oxid
injuri
neuron
morpholog
character
dendrit
bead
fragment
accumul
oxid
phospholipid
cytoplasm
pattern
damag
mainli
found
demyelin
cortic
lesion
haider
et
al
tumefact
demyelin
variant
ms
character
lesion
pseudotumor
appear
size
often
larger
cm
cystic
chang
ring
enhanc
mri
may
mass
effect
enzing
et
al
lesion
solitari
multipl
may
occur
site
cn
includ
spinal
cord
morpholog
typic
activ
demyelin
lesion
inflamm
numer
macrophag
bizarr
reactiv
gliosi
import
know
variant
ms
lesion
often
biopsi
even
resect
differenti
diagnost
workup
may
challeng
especi
small
biopsi
specimen
lucchinetti
et
al
exampl
bizarr
reactiv
gliosi
activ
ms
lesion
may
mimick
glioblastoma
inflammatori
infiltr
may
rais
possibl
vascul
infecti
diseas
even
lymphoprolif
diseas
kuhlmann
et
al
acut
ms
also
refer
diseas
acut
monophas
ill
usual
follow
rapidli
progress
stepwis
deteriori
process
lead
death
within
month
clinic
onset
fig
remyelin
shadow
plaqu
overlap
sharpli
demarc
chronic
inact
plaqu
center
small
vein
next
remyelin
shadow
plaqu
left
character
thinli
myelin
fiber
demonstrad
hematoxylin
eosin
luxol
fast
blue
b
myelin
basic
protein
c
marburg
demyelin
lesion
show
similar
distribut
chronic
ms
plaqu
appear
rel
uniform
within
lesion
one
lesion
correl
monophas
diseas
cours
howev
even
within
acut
ms
often
dissemin
time
shown
variabl
lesion
stage
prinea
et
al
acut
ms
nowaday
extrem
rare
due
avail
effect
antiinflammatori
treatment
intens
care
concentr
sclerosi
balo
variant
ms
character
concentr
ring
demyelin
altern
ring
rel
preserv
myelin
diseas
often
show
acut
onset
progress
steadili
may
even
lead
death
also
show
benign
cours
mild
residu
deficit
suppos
pathophysiolog
mechan
respons
format
concentr
lesion
extens
product
oxid
radic
lead
hypoxialik
tissu
injuri
dyingback
oligodendrogliopathi
lucchinetti
et
al
zone
periplaqu
white
matter
next
activ
demyelin
plaqu
react
express
hypox
precondit
molecul
molecul
protect
effect
help
preserv
small
ring
myelin
case
aggress
lesion
progress
howev
oxid
tissu
injuri
extend
beyond
protect
tissu
ring
lead
new
ring
demyelin
may
final
end
pattern
concentr
demyelin
preserv
myelin
nmo
diseas
entiti
distinct
ms
character
inflammatori
demyelin
primarili
affect
spinal
cord
optic
nerv
disord
also
term
devic
diseas
accord
one
first
descript
date
nmo
long
consid
topograph
restrict
form
ms
although
soon
becam
clear
nmo
patient
differ
classic
ms
term
diseas
cours
treatment
requir
lesion
morpholog
particular
reflect
promin
perivascular
immunoglobulin
deposit
complement
activ
lucchinetti
et
al
discoveri
autoantibodi
astrocyt
waterchannel
major
nmo
patient
lennon
et
al
import
step
toward
classif
nmo
distinct
entiti
featur
incorpor
current
publish
diagnost
consensu
criteria
adult
patient
nmo
criteria
base
core
clinic
characterist
antibodi
statu
specif
mri
requir
tabl
wingerchuk
et
al
allow
inclus
spatial
limit
form
isol
optic
neuriti
myeliti
extens
form
diseas
cerebr
diencephal
brainstem
lesion
spectrum
nmo
socal
nmosd
classic
nmo
demyelin
lesion
usual
locat
optic
nerv
myelon
myelon
lesion
typic
overlap
gray
matter
extend
three
vertebr
segment
fig
ac
moreov
lesion
may
affect
brainstem
except
caus
demyelin
lesion
brain
pittock
et
al
wingerchuk
et
al
lesion
nmosd
present
differ
morpholog
featur
misu
et
al
classic
pattern
character
demyelin
necrosi
loss
axon
astrocyt
lead
cystic
cavit
loss
glial
fibrillari
acid
protein
immunoreact
activ
stage
inflammatori
infiltr
often
contain
eosinophil
granulocyt
fig
next
macrophag
lymphocyt
deposit
igg
fig
igm
well
activ
complement
fig
lucchinetti
et
al
lesion
myelin
mildli
affect
patholog
mainli
concentr
astrocyt
select
loss
fig
e
andor
deposit
complement
loss
perivascular
astrocyt
process
accumul
bizarr
astrocyt
bead
clump
cell
process
socal
clasmatodendrosi
fig
f
lesion
preserv
myelin
loss
may
show
apoptot
oligodendroycyt
expans
extracellular
space
vacuol
consist
intramyelin
edema
fig
ah
lesion
floor
fourth
ventricl
often
show
intens
inflamm
loss
reactiv
glial
fibrillari
acid
proteinposit
astrocyt
preserv
myelin
whether
differ
morpholog
pattern
repres
differ
lesion
age
reflect
variabl
pathogenet
process
present
unclear
loss
activ
nmo
lesion
contrast
activ
lesion
ms
charater
upregul
reactiv
astrocyt
howev
chronic
inact
demyelin
ms
plaqu
may
sometim
absent
roemer
et
al
may
give
rise
erron
nmo
diagnosi
deposit
complement
immunoglobulin
perivascular
astrocyt
process
show
r
h
oftberg
h
lassmann
hightest
concentr
consist
current
concept
humor
autoimmun
mediat
diseas
distinguish
ms
howev
still
unclear
nmo
lesion
particular
predilect
optic
nerv
myelon
adem
acut
monophas
inflammatori
demyelin
diseas
cn
although
occur
age
mainli
affect
children
young
adult
wingerchuk
diseas
may
preced
infecti
diseas
less
frequent
vaccin
wingerchuk
karussi
petrou
season
accumul
diseas
winter
spring
month
report
dale
et
al
leak
et
al
clinic
diagnost
criteria
current
avail
pediatr
age
group
includ
neurolog
symptom
specif
mri
featur
summar
tabl
krupp
et
al
subgroup
patient
adem
antibodi
conform
epitop
mog
serum
antibodi
particularli
preval
children
use
biomark
relaps
variant
adem
multiphas
dissemin
encephalomyel
mdem
adem
follow
episod
optic
neuriti
ademon
recurr
mdem
either
affect
diagnost
criteria
neuromyel
optica
spectrum
disord
nmosd
adult
patient
wingerchuk
et
al
antibodyposit
follow
requir
least
one
core
clinic
featur
posit
antibodi
reason
exclus
altern
caus
antibodyneg
unknown
follow
requir
least
two
core
clinic
featur
one
optic
neuriti
acut
myeliti
letm
area
postrema
syndrom
dissemin
space
fulfil
addit
mri
requir
b
neg
test
antibodi
use
best
avail
detect
method
test
unavail
reason
exclus
altern
caus
core
clinic
featur
optic
neuriti
acut
myeliti
area
postrema
syndrom
hiccup
nausea
andor
vomit
acut
brainstem
syndrom
narcolepsi
acut
diencephal
clinic
syndrom
nmosdtyp
diencephal
mri
lesion
symptomat
cerebr
syndrom
nmosdtyp
brain
lesion
b
addit
magnet
reson
imag
mri
requir
antibodyneg
nmosd
optic
neuriti
either
normalnonspecif
mri
gadolinium
enhanc
lesion
extend
optic
nerv
length
involv
optic
chiasm
r
h
oftberg
h
lassmann
differ
brain
loci
occur
site
relaps
cohen
et
al
may
reflect
either
specif
suscept
antigen
modif
affect
brain
area
local
infect
rate
recurr
variant
adem
report
onethird
patient
anlar
et
al
clinic
differenti
ms
patient
particularli
challeng
characterist
lesion
adem
consist
small
vein
surround
foami
macrophag
without
tcelldomin
inflammatori
infiltr
fig
adjac
parenchyma
show
activ
demyelin
macrophag
contain
luxol
fast
diagnost
criteria
acut
dissemim
encephalomyel
krupp
et
al
follow
requir
first
multifoc
clinic
central
nervou
system
event
presum
inflammatori
demyelin
caus
encephalopathi
explain
fever
abnorm
brain
magnet
reson
imag
mri
diffus
poorli
limit
larg
cm
lesion
predominantli
involv
cerebr
white
matter
b
hypointens
lesion
white
matter
rare
c
deep
graymatt
lesion
eg
thalamu
basal
ganglia
present
new
clinic
mri
find
month
symptom
onset
blueposit
myelin
compon
neutral
lipid
fig
b
c
demyelin
restrict
perivascular
region
axon
rel
preserv
also
show
featur
acut
injuri
young
et
al
vessel
wall
may
sometim
show
fibrin
exud
adjac
parenchyma
may
undergo
necrosi
indic
overlap
adem
acut
hemorrhag
leukoenceph
typic
adem
demyelin
periven
lesion
appear
histolog
age
lesion
locat
throughout
cn
limit
singl
region
although
numer
white
matter
lesion
also
involv
cortex
thalamu
basal
ganglia
tenembaum
et
al
involv
spinal
cord
brainstem
cerebellum
also
common
although
occurr
nonconflu
periven
lesion
characterist
adem
distinguish
larg
confluent
periven
lesion
ms
young
et
al
occasion
patient
clincal
histori
suggest
adem
patholog
overlap
ms
whether
repres
differ
pathogen
process
eg
antimog
antibodyassoci
adem
patient
higher
likelihood
convert
ms
remain
clarifi
adem
usual
preced
infecti
diseseas
less
frequent
vaccin
shown
myelin
peptid
resembl
antigen
virus
influenza
viru
epsteinbarr
viru
human
coronaviru
giovannoni
et
al
thu
postul
infecti
agent
may
stimul
cell
subsequ
attack
similar
even
ident
cn
epitop
altern
direct
infect
brain
parenchyma
expos
cn
antigen
immun
system
affect
bbb
trigger
autoimmun
diseas
steiner
kennedi
final
shown
certain
mhc
class
ii
allel
associ
condit
woodi
et
al
mog
minor
myelin
protein
express
surfac
cn
myelin
sheath
delarass
et
al
mog
belong
immunoglobulin
superfamili
believ
play
role
surfac
receptor
cell
adhes
molecul
martini
schachner
antibodi
subclass
mog
found
serum
patient
inflammatori
demyelin
includ
subgroup
patient
adem
ademon
seroneg
nmosd
monophas
recurr
isol
optic
neuriti
transvers
myeliti
mdem
nmethyldaspart
receptor
enceph
overlap
demyelin
syndrom
rare
ms
di
pauli
et
al
mader
et
al
probstel
et
al
kitley
et
al
kitley
et
al
rostasi
et
al
rostasi
et
al
huppk
et
al
sato
et
al
titula
et
al
hoftberg
et
al
baumann
et
al
jariu
et
al
detect
mog
antibodi
serum
csf
patient
depend
use
appropri
test
method
conserv
conform
protein
live
cellbas
assay
transfect
fulllength
human
mog
mog
antibodi
test
method
serv
sensit
specif
diagnost
marker
mog
antibodi
particularli
preval
among
pediatr
adem
patient
occur
children
mog
antibodyposit
adem
show
characterist
mri
pattern
larg
hazi
bilater
lesion
wide
anatom
involv
includ
myelon
longitudin
extens
transvers
myeliti
baumann
et
al
mog
antibodi
usual
transient
patient
adem
associ
monophas
diseas
cours
probstel
et
al
often
persist
patient
optic
neuriti
myeliti
may
associ
relaps
cours
sever
disabl
substanti
number
patient
jariu
et
al
demyelin
diseas
associ
mog
antibodi
often
difficult
categor
patient
meet
diagnost
criteria
antibodyposit
nmosd
other
classifi
ms
sinc
assum
mog
antibodyposit
patient
underli
immunopathogenesi
requir
therapi
suggest
may
use
subsum
distinct
diseas
entiti
import
note
therapeut
respons
mog
antibodyposit
patient
similar
nmo
differ
ms
patient
jariu
et
al
neuropatholog
mogantibodi
associ
demyelin
describ
patient
relaps
remit
ms
atyp
demyelin
clinic
isol
syndrom
adem
nmosd
tabl
konig
et
al
di
pauli
et
al
spadaro
et
al
jariu
et
al
wang
et
al
irrespect
clinic
nosolog
case
show
demyelin
featur
ms
pattern
welldemarc
r
h
oftberg
h
lassmann
confluent
plaqu
loss
myelin
fig
rel
preserv
axon
numer
macrophag
wellpreserv
astrocyt
inflammaotri
infiltr
predominant
compos
perivascular
parenchym
cell
perivascular
b
cell
lesion
character
rel
wellpreserv
partli
mogneg
oligodendrocyt
like
compat
preoligodendrocyt
fig
b
c
deposit
termin
complement
complex
indic
complementmedi
demyelin
fig
whether
mog
antibodi
pathogenet
role
diseas
format
unclear
differ
eae
anim
model
indic
mog
antibodi
induc
demyelinatin
vitro
vivo
linington
et
al
zhou
et
al
howev
exclud
human
repres
bystand
phenomenon
secondari
immun
reaction
even
may
mediat
benefici
effect
reindl
et
al
human
eae
produc
unintent
inocul
vaccin
cn
tissu
case
describ
worker
slaughterhous
repeatedli
expos
aerosol
brain
tissu
develop
polyradiculoneuropathi
ademlik
condit
lachanc
et
al
moreov
human
eae
occur
associ
rabi
vaccin
use
vaccin
contain
brain
tissu
sempletyp
rabi
vaccin
stuart
krikorian
kulkarni
et
al
treatment
fresh
brain
cell
lyophil
brain
tissu
use
altern
medicin
jelling
seitelberg
patient
surviv
show
monophas
selflimit
diseas
without
evid
relaps
reminisc
clinic
patholog
featur
adem
inflammatori
demyelin
polyneuropathi
lachanc
et
al
rare
subset
patient
howev
show
patholog
pictur
close
resembl
acut
ms
uchimura
shiraki
jelling
seitelberg
detail
immunopatholog
analysi
one
case
reveal
close
similar
regard
inflamm
demyelin
neurodegner
acut
ms
essenti
patholog
featur
differ
seen
eae
anim
model
primat
rodent
hoftberg
et
al
howev
none
patient
develop
chronic
diseas
activ
sensit
ceas
patient
surviv
acut
subacut
diseas
episod
